{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:59:43Z","timestamp":1790103583447,"version":"4.0.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Research Project of Universities in Anhui Province","award":["No. 2023AH052768"],"award-info":[{"award-number":["No. 2023AH052768"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Autoimmune encephalitis in children often presents with neuropsychiatric symptoms and seizures and may progress to secondary epilepsy with prolonged functional impairment. Immunotherapy is the principal disease-modifying treatment, whereas comprehensive nursing care supports safety, complication prevention, rehabilitation, and continuity of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 13-year-old girl presented with a 2-month history of intermittent dizziness and poor appetite, followed by abnormal behavior, mood disturbance, visual hallucinations, and seizures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      Based on characteristic neuropsychiatric manifestations, positive anti-\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -methyl-\n                      <jats:sc>d<\/jats:sc>\n                      -aspartate receptor antibodies in cerebrospinal fluid and serum, and abnormal electroencephalographic findings, the patient was diagnosed with anti-NMDAR autoimmune encephalitis complicated by secondary epilepsy. Infectious encephalitis was initially considered.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient received first-line immunotherapy including high-dose corticosteroids and intravenous immunoglobulin, followed by plasma exchange and second-line rituximab therapy. Antiepileptic drugs and anti-infective treatments were administered as indicated. Whole-process nursing care was implemented across acute, intensive care, rehabilitation, and post-discharge phases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>After multidisciplinary treatment and nursing support, the patient regained clear consciousness with improved cognition and communication. Lower-limb muscle strength improved to grade 4\/5, seizure frequency markedly decreased, and independent ambulation was achieved. At 3-month follow-up, no relapse was reported and the patient had returned to school.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case highlights the importance of structured seizure safety management, strict infection prevention during immunotherapy, individualized rehabilitation guidance, and family-centered continuing care in pediatric anti-NMDAR autoimmune encephalitis complicated by secondary epilepsy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050816","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:02:03Z","timestamp":1789750923000},"page":"e50816","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Nursing care of a pediatric patient with anti-NMDAR encephalitis complicated by secondary epilepsy"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2355-8312","authenticated-orcid":false,"given":"Qionglei","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Nursing, Clinical College of Anhui Medical University, Hefei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nursing, Clinical College of Anhui Medical University, Hefei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis.","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3389\/fneur.2019.00906","article-title":"Pediatric autoimmune encephalitis: case series from two Chinese tertiary pediatric neurology centers.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Neurol"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pediatrneurol.2022.11.008","article-title":"Seizure evolution and outcome in pediatric autoimmune encephalitis.","volume":"139","author":"Woo","year":"2023","journal-title":"Pediatr Neurol"},{"key":"R5-20260922","doi-asserted-by":"crossref","first-page":"880693","DOI":"10.3389\/fped.2022.880693","article-title":"Clinical characteristics and short-term prognosis of children with antibody-mediated autoimmune encephalitis: a single-center cohort study.","volume":"10","author":"Kang","year":"2022","journal-title":"Front Pediatr"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"e1127","DOI":"10.1212\/NXI.0000000000001127","article-title":"Anti-NMDAR encephalitis in the Netherlands, focusing on late-onset patients and antibody test accuracy.","volume":"9","author":"Bastiaansen","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R8-20260922","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2018.12.015","article-title":"EEG findings in NMDA encephalitis - a systematic review.","volume":"65","author":"Gillinder","year":"2019","journal-title":"Seizure"},{"key":"R13-20260922","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3988\/jcn.2023.0242","article-title":"Outcome and sequelae of autoimmune encephalitis.","volume":"20","author":"Kvam","year":"2024","journal-title":"J Clin Neurol"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"e13897","DOI":"10.1111\/hex.13897","article-title":"Family-centred care interventions for children with chronic conditions: a scoping review.","volume":"27","author":"Chow","year":"2024","journal-title":"Health Expect"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pediatrneurol.2022.05.004","article-title":"Autoimmune encephalitis in children.","volume":"132","author":"Hardy","year":"2022","journal-title":"Pediatr Neurol"},{"key":"R16-20260922","first-page":"1","article-title":"Recent advances in autoimmune encephalitis.","volume":"82","author":"Ferreira","year":"2024","journal-title":"Arq Neuropsiquiatr"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"1408606","DOI":"10.3389\/fneur.2024.1408606","article-title":"A systematic review of the epidemiology of pediatric autoimmune encephalitis: disease burden and clinical decision-making.","volume":"15","author":"Santoro","year":"2024","journal-title":"Front Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:03:35Z","timestamp":1790100215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050816"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":13,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050816","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2025-11-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}